Cardiovascular health in African Americans: a scientific statement from the American Heart Association
MR Carnethon, J Pu, G Howard, MA Albert… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Population-wide reductions in cardiovascular disease incidence
and mortality have not been shared equally by African Americans. The burden of …
and mortality have not been shared equally by African Americans. The burden of …
Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement
Importance Systematic reviews and meta-analyses of individual participant data (IPD) aim to
collect, check, and reanalyze individual-level data from all studies addressing a particular …
collect, check, and reanalyze individual-level data from all studies addressing a particular …
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
M Kinoshita, K Yokote, H Arai, M Iida… - … of atherosclerosis and …, 2018 - jstage.jst.go.jp
Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …
Fibrinogen and atherosclerotic cardiovascular diseases—review of the literature and clinical studies
Atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease,
cerebrovascular disease, and peripheral arterial disease, represent a significant cause of …
cerebrovascular disease, and peripheral arterial disease, represent a significant cause of …
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
M Ząbczyk, RAS Ariëns, A Undas - Cardiovascular research, 2023 - academic.oup.com
Fibrinogen conversion into insoluble fibrin and the formation of a stable clot is the final step
of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated …
of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated …
[HTML][HTML] Fibrin (ogen) in human disease: both friend and foe
Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma
at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 …
at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 …
C-reactive protein, fibrinogen, and cardiovascular disease prediction
Emerging Risk Factors … - New England Journal of …, 2012 - Mass Medical Soc
Background There is debate about the value of assessing levels of C-reactive protein (CRP)
and other biomarkers of inflammation for the prediction of first cardiovascular events …
and other biomarkers of inflammation for the prediction of first cardiovascular events …
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
S Kaptoge, SRK Seshasai, P Gao… - European heart …, 2014 - academic.oup.com
Aims Because low-grade inflammation may play a role in the pathogenesis of coronary heart
disease (CHD), and pro-inflammatory cytokines govern inflammatory cascades, this study …
disease (CHD), and pro-inflammatory cytokines govern inflammatory cascades, this study …
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart …
PB Lockhart, AF Bolger, PN Papapanou… - Circulation, 2012 - Am Heart Assoc
A link between oral health and cardiovascular disease has been proposed for more than a
century. Recently, concern about possible links between periodontal disease (PD) and …
century. Recently, concern about possible links between periodontal disease (PD) and …
[HTML][HTML] Diabetes mellitus, fasting glucose, and risk of cause-specific death
Emerging Risk Factors … - New England Journal of …, 2011 - Mass Medical Soc
Background The extent to which diabetes mellitus or hyperglycemia is related to risk of
death from cancer or other nonvascular conditions is uncertain. Methods We calculated …
death from cancer or other nonvascular conditions is uncertain. Methods We calculated …